-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
The applicability of home blood pressure measurement in clinical practice: A review of literature
(2352) Views (624) Full article downloads
Authors: Willem J Verberk, Abraham A Kroon, Heidi A Jongen-Vancraybex, Peter W de Leeuw
Published Date January 2007
Volume 2007:3(6) Pages 959 - 966
DOI: http://dx.doi.org/10.2147/VHRM.S
Willem J Verberk, Abraham A Kroon, Heidi A Jongen-Vancraybex, Peter W de Leeuw
University Hospital Maastricht, Department of Internal Medicine and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
Purpose: To review the literature on home blood pressure measurement (HBPM), to examine its validity and applicability for clinical practice and to provide recommendations regarding HBPM assessment.
Findings: HBPM can eliminate the white coat effect and offers the possibility to obtain multiple measurements under standardized conditions, which increases knowledge of overall blood pressure value. Although it is not entirely capable of replacing ambulatory blood pressure measurement (ABPM), HBPM correlates better with target organ damage and cardiovascular mortality than office blood pressure measurement (OBPM), it enables prediction of sustained hypertension in patients with borderline hypertension, and proves to be an appropriate tool for assessing drug efficacy. Additional advantages of HBPM are that it may increase drug compliance and patient’s awareness of hypertension. Overall, OBPM yield higher blood pressure values than HBPM. Differences between OBPM and HBPM tend to increase with age and are generally higher in patients without antihypertensive treatment than in patients with antihypertensive treatment.
Recommendations: Measurements should be performed according to accepted guidelines and recordings should be performed with a memory equipped automatic validated device. From the data reviewed here, we recommend that HBPM be assessed monthly by taking two measurements in the morning within 1 hour after awakening and two in the evening for three consecutive days, the data from the first day should be dismissed. A subject should be labeled hypertensive if his/her HBPM value is equal to or greater than 137 mmHg systolic and/or 84 mmHg diastolic.
Keywords: blood pressure, hypertension, self-measurement, home measurement, ambulatory measurement, adherence
Readers of this article also read:
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
Reliability of an instrument to determine lower limb comfort in professional football
Differential susceptibility of HIV strains to innate immune factors in human cervical-vaginal secretions
Update on vaccine development for renal cell cancer
ABO and rhesus blood group distribution in Kurds
A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Walking just after a meal seems to be more effective for weight loss than waiting for one hour to walk after a meal
Erratum
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review




